載入...
EGFR activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity
In lung cancer patients whose tumors harbor activating mutations in the epidermal growth factor receptor (EGFR), increased responses to platinum-based chemotherapies are seen compared to wild-type cancers. However, the mechanisms underlying this association have remained elusive. Here, we describe a...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3823187/ https://ncbi.nlm.nih.gov/pubmed/23966292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0044 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|